Survival Benefit of Neoadjuvant Chemotherapy in Non-small Cell Lung Cancer: An Updated Meta-Analysis of 13 Randomized Control Trials-Reference-Cited by-同舟云学术

Survival Benefit of Neoadjuvant Chemotherapy in Non-small Cell Lung Cancer: An Updated Meta-Analysis of 13 Randomized Control Trials

Published:2010-04 Issue:4 Volume:5 Page:510-516
ISSN:1556-0864
Container-title:Journal of Thoracic Oncology
language:en
Short-container-title:Journal of Thoracic Oncology

Author:

Song Wei-An,Zhou Nai-Kang,Wang Wei,Chu Xiang-Yang,Liang Chao-Yang,Tian Xiao-Dong,Guo Jun-Tang,Liu Xi,Liu Yang,Dai Wei-Min

Publisher

Elsevier BV

Subject

Pulmonary and Respiratory Medicine,Oncology

Reference45 articles.

1. A systematic review and meta-analysis of the literature: chemotherapy and surgery versus surgery alone in non-small cell lung cancer;Burdett;J Thorac Oncol,2006

2. Preoperative chemotherapy in patients with resectable non-small cell lung cancer: results of the MRC LU22/NVALT 2/EORTC 08012 multicentre randomised trial and update of systematic review;Gilligan;Lancet,2007

3. A phase III randomized study of surgery alone or surgery plus preoperative gemcitabine-cisplatin in early-stage non-small cell lung cancer (NSCLC): Follow-up data of Ch.E.S.T.;Scagliotti;J Clin Oncol,2008

4. Failure of the perioperative PCV neoadjuvant polychemotherapy in resectable bronchogenic non-small cell carcinoma. Results from a randomized phase II trial;Dautzenberg;Cancer,1990

5. A randomized trial comparing preoperative chemotherapy plus surgery with surgery alone in patients with non-small-cell lung cancer;Rosell;N Engl J Med,1994

Cited by 178 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Induction therapy for non–small cell lung cancer;The Journal of Thoracic and Cardiovascular Surgery;2024-08

2. What Does N2 Lymph Node Involvement Mean for Patients with Non-Small Cell Lung Cancer (NSCLC)?—A Review of Implications for Diagnosis and Treatment;Cancers;2024-07-26

3. The role of immunotherapy in early-stage and metastatic NSCLC;Pathology and Oncology Research;2024-07-04

4. Pathologic Response and Survival after Neoadjuvant Chemotherapy with Bevacizumab Followed by Surgery for Clinical Stage II/IIIA Nonsquamous Non-Small-Cell Lung Cancer: Results from a Phase II Feasibility Study (NAVAL);Cancers;2024-06-27

5. Efficacy of neoadjuvant chemotherapy combined with surgery in patients with nonsmall cell lung cancer: A meta‐analysis;The Clinical Respiratory Journal;2024-05